Key result
Epicardial cryoablation during LVAD implant can trigger severe inflow cannula obstruction from myocardial edema.
Why the study?
Ventricular tachycardia after LVAD implantation portends a significantly worse prognosis, and technical difficulties of post-implant ablation have led to proposals for concurrent surgical ablation at the time of LVAD implantation, which remains in its nascent phase without consensus on optimal management.
Case Report (n=1)
No
This case report is the first to describe massive acute myocardial edema causing LVAD inflow cannula obstruction after concomitant epicardial cryoablation, demonstrating successful management with temporary RV support, LVAD speed reduction, and bedside stellate ganglion blockade for recurrent VT.
Answers are grounded in this paper and cite their sources.
Urges caution with concomitant epicardial cryoablation during LVAD implantation; leaves open its safety in broader populations.
Ventricular tachycardia (VT) is a common comorbidity in patients with end-stage heart failure. For those that require left ventricular assist device (LVAD) support, the occurrence of VT post LVAD implantation portends a significantly worse prognosis—in terms of both morbidity and mortality. Owing to the technical difficulties of performing VT ablation after LVAD implantation, concurrent surgical ablation at time of surgery has been proposed as a strategy employed to reduce long-term arrhythmia burden.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2020) conducted a case report in Nonischemic idiopathic cardiomyopathy with acute decompensated heart failure and refractory ventricular tachycardia (n=1). Concomitant epicardial surgical cryoablation at time of LVAD implantation and subsequent percutaneous bilateral stellate ganglion blockade was evaluated on Resolution of LVAD inflow cannula obstruction and termination of postoperative ventricular tachycardia. Concomitant epicardial cryoablation during LVAD implant caused severe myocardial edema and inflow obstruction (flows <2 L/min), resolved by Day 14 with RV support, while stellate ganglion block terminated VT.
Synapse has enriched 10 related papers. Consider them for comparative context: